| 000 | 01891 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517010720.0 | ||
| 264 | 0 | _c20150501 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1530-0307 | ||
| 024 | 7 |
_a10.1038/labinvest.2014.163 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnderberg, Robert J | |
| 245 | 0 | 0 |
_aSerum amyloid A and inflammation in diabetic kidney disease and podocytes. _h[electronic resource] |
| 260 |
_bLaboratory investigation; a journal of technical methods and pathology _cMar 2015 |
||
| 300 |
_a250-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xblood |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aInflammation _xblood |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Diseases _xblood |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPodocytes _xdrug effects |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aSerum Amyloid A Protein _xgenetics |
| 650 | 0 | 4 |
_aThiocarbamates _xpharmacology |
| 700 | 1 | _aMeek, Rick L | |
| 700 | 1 | _aHudkins, Kelly L | |
| 700 | 1 | _aCooney, Sheryl K | |
| 700 | 1 | _aAlpers, Charles E | |
| 700 | 1 | _aLeboeuf, Renee C | |
| 700 | 1 | _aTuttle, Katherine R | |
| 773 | 0 |
_tLaboratory investigation; a journal of technical methods and pathology _gvol. 95 _gno. 3 _gp. 250-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/labinvest.2014.163 _zAvailable from publisher's website |
| 999 |
_c24479725 _d24479725 |
||